Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Guillaume Grenet

Hospices Civils de Lyon

France

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in France Professors in Biostatistics Biostatistics professors in France

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (9)

Jacob Stidsen

University of Southern Denmark

DENMARK

View details

Magali Labadie

Head of department

FRANCE

View details

Dominique Vodovar

Université Paris Cité

FRANCE

View details

Rémy Boussageon

Université Claude Bernard Lyon 1

FRANCE

View details

Jessica Otte

Member, Therapeutics Initiative

The University of British Columbia

CANADA

View details

Behrouz Kassai

Professor

Université Claude Bernard Lyon 1

FRANCE

View details

Jean‐Christophe Lega

Professor

University of Lyon

FRANCE

View details

Greg Carney

The University of British Columbia

CANADA

View details

Emmanuel Massy

Hospices Civils de Lyon

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guillaume Grenet

Research Interests

Make your next move.

Explore related searches

Articles (20)

Reliability of accelerated confirmatory trials during the COVID-19 pandemic: the consequences of low pretrial plausibility

Reversing the burden of evidence: a needed evolution in GRADE to address publication bias

Use of sodium-glucose cotransporter-2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia

Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review

Gabapentinoids and Neuropathic Pain: Evaluation of the Quality of Randomised Controlled Trials: An Umbrella Review.

Vitamin D lacks efficacy: A re‐analysis of a systematic review using the REB method

Efficacy and safety of balneotherapy in rheumatology: a systematic review and meta-analysis

Adverse reactions of liquorice consumed in the diet: a 10-year retrospective study of poison centres in France

Thyroid testing in primary hypothyroidism

Pharmacotherapy for mild hypertension.

Temporal evolution of publication bias in drug safety assessment: A case study on association between osteonecrosis of the jaw and bisphosphonates.

Self-reported health effects after one year from a viper bite: A prospective study from France

Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study.

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists.

How publication bias overestimates the risk of atypical femoral fracture and osteonecrosis of the jaw associated with bisphosphonate use: A meta-epidemiological study.

Acute Thyroid Hormone Exposure in Children: A National Retrospective Study Using Health Data Routinely Collected by the French Poison Control Centers

Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological study.

Mushroom Poisoning-Related Cardiac Toxicity: A Case Report and Systematic Review

Estimating individualized treatment effects using an individual participant data meta-analysis.

Exposure to ammonia solution due to substance use: a retrospective study from the French poison centres database (2009–2018)

Collaborators (9)

Jacob Stidsen

Magali Labadie

Dominique Vodovar

Rémy Boussageon

Jessica Otte

Behrouz Kassai

Jean‐Christophe Lega

Greg Carney

Emmanuel Massy

Make your next move.